1. Home
  2. CDT vs XELB Comparison

CDT vs XELB Comparison

Compare CDT & XELB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • XELB
  • Stock Information
  • Founded
  • CDT 2019
  • XELB 2011
  • Country
  • CDT United States
  • XELB United States
  • Employees
  • CDT N/A
  • XELB N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • XELB Multi-Sector Companies
  • Sector
  • CDT Health Care
  • XELB Miscellaneous
  • Exchange
  • CDT Nasdaq
  • XELB Nasdaq
  • Market Cap
  • CDT 11.1M
  • XELB 9.6M
  • IPO Year
  • CDT N/A
  • XELB N/A
  • Fundamental
  • Price
  • CDT $1.15
  • XELB $0.37
  • Analyst Decision
  • CDT
  • XELB
  • Analyst Count
  • CDT 0
  • XELB 0
  • Target Price
  • CDT N/A
  • XELB N/A
  • AVG Volume (30 Days)
  • CDT 8.8M
  • XELB 45.0K
  • Earning Date
  • CDT 03-04-2025
  • XELB 04-15-2025
  • Dividend Yield
  • CDT N/A
  • XELB N/A
  • EPS Growth
  • CDT N/A
  • XELB N/A
  • EPS
  • CDT N/A
  • XELB N/A
  • Revenue
  • CDT N/A
  • XELB $9,337,000.00
  • Revenue This Year
  • CDT N/A
  • XELB N/A
  • Revenue Next Year
  • CDT N/A
  • XELB $69.64
  • P/E Ratio
  • CDT N/A
  • XELB N/A
  • Revenue Growth
  • CDT N/A
  • XELB N/A
  • 52 Week Low
  • CDT $1.13
  • XELB $0.33
  • 52 Week High
  • CDT $392.00
  • XELB $1.06
  • Technical
  • Relative Strength Index (RSI)
  • CDT 31.53
  • XELB 38.49
  • Support Level
  • CDT $1.60
  • XELB $0.35
  • Resistance Level
  • CDT $3.70
  • XELB $0.45
  • Average True Range (ATR)
  • CDT 0.44
  • XELB 0.04
  • MACD
  • CDT 0.09
  • XELB 0.00
  • Stochastic Oscillator
  • CDT 0.78
  • XELB 13.63

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain design, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

Share on Social Networks: